OCI-Ly3 In Vitro Anti-Tumor Efficacy Assay

CAT#: ITS-0123-YF4932
Target Cell Organism: Human
Target Cell Name: OCI-Ly3
Assay Type: Oncology Efficacy Assays
Assay Overview
This assay is to provide OCI-Ly3-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
OCI-Ly3
Target Cell Organism
Human
Target Cell Background
Human B-cell non-Hodgkin lymphoma cell line established in 1983 from the bone marrow sample of a 52-year-old man with B-cell non-Hodgkin lymphoma
Related Diseases
Lymphoma
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.
Assay Type
Oncology Efficacy Assays
For Research Use Only | Not For Clinical Use
Online Inquiry